Anders D Hove Insider Trading $ANAC Anacor Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anders D Hove.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anders D Hove. Anders D Hove is Director in ARCA biopharma, Inc. ($ABIO) and Director in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in Edge Therapeutics, Inc. ($EDGE).
Anders D Hove in Anacor Pharmaceuticals, Inc.
Trading Symbol: ANACIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anders D Hove: Director
Holdings: 0 shares
Latest Transaction: Jun 24 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Anders D Hove in Anacor Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, ABIO, EDGE, TRBN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.20 | 12,500 | 65,000 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.74 | 15,000 | 101,100 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.92 | 30,000 | 207,600 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | D | 99.25 | 33,886 | 3,363,186 | 0 | 33.9 K to 0 (-100.00 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 98.93 | 72,385 | 7,161,048 | 0 | 72.4 K to 0 (-100.00 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 99.41 | 199,865 | 19,868,580 | 72,385 | 272.3 K to 72.4 K (-73.41 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 100.60 | 81,631 | 8,212,079 | 272,250 | 353.9 K to 272.3 K (-23.07 %) |
Apr 15 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | C | 31.05 | 257,647 | 7,999,939 | 353,881 | 96.2 K to 353.9 K (+267.73 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 71.40 | 400 | 28,560 | 96,234 | 96.6 K to 96.2 K (-0.41 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 70.05 | 3,868 | 270,953 | 96,634 | 100.5 K to 96.6 K (-3.85 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 75.57 | 6,820 | 515,387 | 100,502 | 107.3 K to 100.5 K (-6.35 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 74.13 | 200 | 14,826 | 107,322 | 107.5 K to 107.3 K (-0.19 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 73.29 | 2,272 | 166,515 | 107,522 | 109.8 K to 107.5 K (-2.07 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 72.15 | 13,000 | 937,950 | 109,794 | 122.8 K to 109.8 K (-10.59 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 71.44 | 99,981 | 7,142,643 | 122,794 | 222.8 K to 122.8 K (-44.88 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 70.33 | 102,760 | 7,227,111 | 222,775 | 325.5 K to 222.8 K (-31.57 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 111.25 | 900,000 | 100,125,000 | 325,535 | 1.2 M to 325.5 K (-73.44 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 117.36 | 40,000 | 4,694,400 | 33,886 | 73.9 K to 33.9 K (-54.14 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | J | 0.00 | 73,092 | 0 | 73,886 | 794 to 73.9 K (+9,205.54 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | J | 0.00 | 372,982 | 0 | 1,225,535 | 1.6 M to 1.2 M (-23.33 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 103.60 | 100,295 | 10,390,562 | 1,598,517 | 1.7 M to 1.6 M (-5.90 %) |
Nov 05 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | J | 0.00 | 372,982 | 0 | 1,598,517 | 1.2 M to 1.6 M (+30.43 %) |
Nov 05 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | J | 0.00 | 1,500,000 | 0 | 1,225,535 | 2.7 M to 1.2 M (-55.04 %) |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
Page: 1